Camoguis, Jessa B.
HRN: 21-74-05 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/01/2022
CIPROFLOXACIN 500MG (TAB)
08/02/2022
08/08/2022
PO
500mg
BID
Typhoid Fever
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes